Want to join the conversation?
$SCHL affirmed its FY17 outlook. The company expects total FY17 revenue to be within $1.7-1.8Bil and diluted EPS from continuing operations in the range of $1.60-1.70, excluding one-time items. The company continues to expect free cash flow in the range of $40-50MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.